Hjem › Prostatakreft › Kentucky
Kliniske studier for Prostatakreft i Kentucky
19 studier for Prostatakreft søker deltakere på steder i Kentucky.
Byer i Kentucky
Offisiell studietekst (engelsk)
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- CommonSpirit Saint Joseph Hospital - Bardstown, Bardstown
- Commonwealth Cancer Center-Corbin, Corbin
- Saint Elizabeth Healthcare Edgewood, Edgewood
- og 5 flere
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
Alder 40 til 75 · Alle kjønn · Oppdatert 2. okt. 2026 · NCT05334069Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
- Saint Elizabeth Healthcare Edgewood, Edgewood
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT06632977Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
- University of Kentucky/Markey Cancer Center, Lexington
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 30. sep. 2026 · NCT03866382Prostate Cancer Risk Identification in a Multi-Ethnic Cohort: a Prospective US-based Multi-center Validation Study of Proclarix
- Graves Gilbert Clinic, Bowling Green
RekruttererObservasjonsstudie
Alder 40 til 75 · Menn · Oppdatert 28. sep. 2026 · NCT07543757A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
- University of Louisville Health - James Graham Brown Cancer Center, Louisville
- Norton Cancer Institute, Louisville
RekruttererFase 3
Alder 18 og eldre · Menn · Oppdatert 22. sep. 2026 · NCT07213674High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers
- Robley Rex VA Medical Center, Louisville, KY, Louisville
RekruttererFase 2
Alder 18 og eldre · Menn · Oppdatert 17. sep. 2026 · NCT05011383A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
- University of Kentucky Chandler Medical Center ( Site 0048), Lexington
RekruttererFase 3
Alder 18 og eldre · Menn · Oppdatert 17. sep. 2026 · NCT06925737Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
- Baptist Health Hardin, Elizabethtown
- Saint Joseph Hospital, Lexington
- Saint Joseph Radiation Oncology Resource Center, Lexington
- og 3 flere
RekruttererFase 3
Alder 18 og eldre · Menn · Oppdatert 10. sep. 2026 · NCT05946213Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
- CommonSpirit Saint Joseph Hospital - Lexington, Lexington
- Saint Joseph Radiation Oncology Resource Center, Lexington
- CommonSpirit Saint Joseph Medical Center - East Lexington, Lexington
RekruttererFase 3
Alder 18 og eldre · Menn · Oppdatert 19. aug. 2026 · NCT04423211Comparing Acupuncture vs. Sham Acupuncture for the Management of Hot Flashes in Prostate Cancer Patients Receiving Hormone Therapy
- University of Kentucky, Lexington
Rekrutterer
Alder 18 til 99 · Alle kjønn · Oppdatert 18. aug. 2026 · NCT07594002Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
- CommonSpirit Saint Joseph Hospital - Bardstown, Bardstown
- Commonwealth Cancer Center-Corbin, Corbin
- CommonSpirit Saint Joseph Hospital - Lexington, Lexington
- og 8 flere
RekruttererFase 3
Alder 18 og eldre · Menn · Oppdatert 14. jul. 2026 · NCT06592924Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine Cells
- University of Kentucky/Markey Cancer Center, Lexington
RekruttererFase 2
Alder 18 og eldre · Menn · Oppdatert 14. jul. 2026 · NCT05691465Pembro With Radiation With or Without Olaparib
- University of Kentucky, Lexington
RekruttererFase 2
Alder 18 og eldre · Menn · Oppdatert 14. jul. 2026 · NCT05568550Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors
- UK Markey Cancer Center, Lexington
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 11. jun. 2026 · NCT05283330A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
- University of Kentucky Markey Cancer Center, Lexington
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 13. feb. 2026 · NCT06778863Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation
- Flaget Memorial Hospital, Bardstown
- Commonwealth Cancer Center-Corbin, Corbin
- Saint Joseph Hospital, Lexington
- og 4 flere
RekruttererFase 2
Alder 18 og eldre · Menn · Oppdatert 29. jan. 2026 · NCT05806515cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
- Baptist Corbin, Corbin
- Baptist Hardin, Elizabethtown
- Baptist Lexington, Lexington
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
Alder 40 og eldre · Alle kjønn · Oppdatert 20. jan. 2026 · NCT05366881A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
- Research Site 115, Louisville
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 21. nov. 2025 · NCT05914116Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
- Saint Joseph Radiation Oncology Resource Center, Lexington
- Saint Joseph Hospital East, Lexington
- University of Kentucky/Markey Cancer Center, Lexington
- og 1 flere
RekruttererFase 3
Alder 18 og eldre · Menn · Oppdatert 11. sep. 2025 · NCT03678025Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.